Succeeding in Fellowship
Jay Mehta, MD
In this presentation, Jay Mehta, MD, will share his experience as a fellowship director and insights from his research on transitions through fellowship to provide strategies for not only surviving but thriving during fellowship. Attendees will come away with at least one or two strategies to help them be successful during this exciting but challenging time in their training.
Introduction to Musculoskeletal Ultrasound for Pediatric Rheumatologists
Edward Oberle, MD, RhMSUS
In this presentation, Edward Oberle, MD, RhMSUS, provides a basic overview of how musculoskeletal (MSKUS) can enhance the care provided by a pediatric rheumatologist. Common ultrasonographic findings seen in juvenile idiopathic arthritis are reviewed. A brief description of opportunities for pediatric rheumatology fellows to further learn about MSKUS and develop their skills is also provided.
Amplified Pain Syndromes in the Pediatric Rheumatology Clinic
William Bernal, MD, MPH, RhMSUS
In this presentation, William Bernal, MD, MPH, RhMSUS, discusses the management of pediatric amplified pain syndromes using multimodal therapies. Approaches that are effective in treating amplified pain syndromes are also effective in improving the function and quality of life for pediatric patients with rheumatic disease.
Approach to Musculoskeletal Radiology
Matt Hammer, MD
In this presentation, Matt Hammer, MD, will provide an overview of imaging rheumatologic disorders from a radiology perspective. This will include how imaging can help make diagnoses and monitor the effectiveness of therapy.
Rheumatology Labs
Dana Gerstbacher, MD, PhD
In this presentation, Dana Gerstbacher, MD, PhD, will describe commonly used lab tests in pediatric rheumatology including inflammatory markers and autoantibodies. We will also discuss the disease associations of the autoantibodies.
Therapeutics in Pediatric Rheumatology: Essential Pharmacology for Safe and Effective Prescribing
Stephen Balevic, MD, MHS
In this presentation, Stephen Balevic, MD, MHS, will provide an overview of the use of biologic and non-biologic DMARDs in the treatment of pediatric rheumatic diseases, with a special emphasis on clinical pharmacology and the fundamentals for safe and effective prescribing.
Immunology Basics
Ed Behrens, MD
In this presentation, Ed Behrens, MD, will discuss the immune system as it operates in health, providing a framework to understand its components and interactions. We will integrate this knowledge to understand the major patterns by which the immune systems malfunctions in disease. The learner is expected to already have a general understanding of the immune system as learned in medical school education to make the best use of this material.
Rheumatologic Emergencies
Martha Rodriguez, MD, PhD
In this presentation, Martha Rodriguez, MD, PhD, will review the approach of the most common rheumatologic emergencies that we see in practice. Clinical presentation, diagnosis and treatment approaches will be discussed.
Pediatric Scleroderma: Challenging Rare Diseases
Suzanne C. Li, MD, PhD
In this presentation, Suzanne C. Li, MD, PhD, will provide an overview of the similarities and differences between two types of pediatric scleroderma, localized scleroderma, and systemic sclerosis. The diagnosis, clinical features, and major morbidities associated with each type will be reviewed. The general approach to the evaluation and management of patients with pediatric scleroderma will be discussed.
Vasculitis (ANCA, Systemic)
Marinka Twilt, MD, MScE, PhD
In this presentation, Marinka Twilt, MD, MScE, PhD, will conduct a case-based discussion about the clinical presentation of childhood ANCA-associated vasculitides. Review the differential diagnosis of pulmonary renal syndrome specifically, and review the current state of evidence for the treatment of childhood AAV.
Introduction to Autoinflammation
Scott Canna, MD
In this presentation, Scott Canna, MD, will use the evaluation of recurrent fevers as an entrée to the expanding world of autoinflammatory disorders. The lecture will highlight practical tips, red flags, occult symptoms, and real-time resources. However, the underlying premise is that a dynamic understanding of innate immunology is a precondition of understanding and appropriately managing suspected monogenic autoinflammatory disease.
Wolf at the Door: Childhood Onset Lupus
Stacey Ardoin, MD, MS
In this presentation, Stacey Ardoin, MD, MS, will conduct a case-based discussion about the approach to diagnosing and treating childhood-onset SLE. Pathophysiology and long-term outcomes will also be reviewed.
Juvenile Dermatomyositis
Stacey Tarvin, MD, MS, FAAP, FARC
Juvenile dermatomyositis (JDM), the most common chronic childhood rheumatic inflammatory muscle disease, will be discussed in this lecture. In this presentation, Stacey Tarvin, MD, MS, FAAP, FARC, will review the clinical presentation and differential diagnosis of childhood myositis. Classification criteria for idiopathic inflammatory myopathy will be discussed. Treatment approaches, prognosis and disease-related emergencies in JDM will be reviewed.
Systemic Inflammation in Children: Systemic JIA, Macrophage Activation Syndrome, and COVID-associated MIS-C
Grant Schulert, MD, PhD
Pediatric rheumatologists frequently evaluate children with unexplained fever and signs of systemic inflammation. In this session, Grant Schulert, MD, PhD, will review the approach to systemic JIA, as well as the related complication macrophage activation syndrome. This session will also review the newly recognized multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19.
Juvenile Idiopathic Arthritis
Pamela Weiss, MD, MSCE
In this presentation, Pamela Weiss, MD, MSCE, covers the JIA classification schema, major clinical features of each JIA category (except systemic), initial treatment approaches, tools to assess JIA disease activity and outcomes, and an introduction to clinical trial designs for JIA.
Approach to Joint Pain; Reactive/Post-Infectious Considerations
T. Brent Graham, MD, MS
This presentation will cover approach to musculoskeletal pain. We will review an approach that will focus on number of joints affected and presence or absence of arthritis to help guide differential based upon categories of disease.